Dopamine receptor-coupling defect in hypertension

Current Hypertension Reports

Volumn 4, Issue 3, 2002, Pages 237-244

  Jose, Pedro A ^a   Eisner, Gilbert M ^b   Felder, Robin A ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN-COUPLED RECEPTOR KINASE 4; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; RGS PROTEIN;

ANIMAL; ENZYMOLOGY; GENETICS; HUMAN; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 0036615804     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-002-0013-6     Document Type: Article

References (93)

1. Jose PA, Eisner GM, Felder RA: Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2000, 2: 174-183.
2. Hussain T, Lokhandwala MF: Renal dopamine receptor function in hypertension. Hypertension 1998, 32: 187-197.
3. Jose PA, Asico LD, Eisner GM, et al.: Effects of costimulation of dopamine D1- and D2-like receptors on renal function. Am J Physiol 1998, 275: R986-R994.
4. Eklof AC: The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol Scand 1997, 160: 311-314.
5. Luippold G, Kuster E, Joos TO, Muhlbauer B: Dopamine D3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 1998, 358: 690-693.
6. Gether U: Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrine Rev 2000, 2190-113.
7. Dohlman HG, Thorner JW: Regulation of G protein-initiated signal transduction in yeast: paradigms and principles. Ann Rev Biochem 2001, 70: 703-754.
8. Sibley DR: New insights into dopaminergic receptor function using antisense and genetically altered animals. Ann Rev Pharmacol Toxicol 1999, 39: 313-41.
9. Glickstein SB, Schmauss C: Dopamine receptor functions: lessions from knockout mice. Pharmacol Ther 2001, 9163-83.
10. Kimura K, White BH, Sidhu A: Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and Go. J Biol Chem 1995, 270: 14672-14678.
11. Lee JWM, Joshi S, Chan JSC, Wong YH: Differential coupling of μ, d, and k opioid receptors to G16-mediated stimulation of phospholipase C. J Neurochem 1998, 70: 2203-2211.
12. Ho MK, Yung LY, Chan JS, et al.: Galpha14 links a variety of Gi- and Gs-coupled receptors to the stimulation of phospholipase C. Br J Pharmacol 2001, 132: 1431-1440.
13. Felder CC, Jose PA, Axelrod J: The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 1989, 248: 171-175.
14. Bertorello A, Aperia A: Na+-K+-ATPase is an effector protein for protein kinase C in renal proximal tubule cells. Am J Physiol 1989, 256: F370-F373.
15. Lezcano N, Mrzljak L, Eubanks S, et al.: Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 2000, 287: 1660-1664.
16. Sidhu A, Kimura K, Uh M, et al.: Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz. J Neurochem 1998, 70: 2459-2467.
17. Mao J, Yuan H, Xie W, et al.: Specific involvement of G proteins in regulation of serum response factor-mediated gene transcription by different receptors. J Biol Chem 1998, 273: 27118-27123.
18. Zheng S, Yu P, Sanada H, et al.: Differential G-protein subunit linkage and regulation of D1 and D5 receptors in renal proximal tubules [abstract]. J Am Soc Nephrol 2001, 12: 478A.
19. Drolet P, Bilodeau L, Chorvatova A, et al.: Inhibition of the T-type Ca2+ current by the dopamine D1 receptor in rat adrenal glomerulosa cells: requirement of the combined action of the Gbg protein subunit and cyclic adenosine 3',5'monophosphate. Mol Endocrinol 1997, 11: 503-514.
20. Albrecht FE, Xu J, Moe OW, et al.: Regulation of NHE-3 activity by G-protein subunits in renal brush border membranes. Am J Physiol Regul Integr Comp Physiol 2000, 278: R1064-R1073.
21. Li XX, Xu J, Zheng S, et al.: D1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2001, 280: R1650-R1656.
22. Felder RA, Seikaly MG, Cody P, et al.: Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990, 15: 560-569.
23. Chen CJ, Vyas SJ, Eichberg J, Lokhandwala MF: Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats. Hypertension 1992, 19: 102-108.
24. Nishi A, Eklöf A-C, Bertorello AM, Aperia A: Dopamine regulation of renal Na+, K+ATPase activity is lacking in Dahl saltsensitive rats. Hypertension 1993, 21: 767-771.
25. O'Connell DP, Ragsdale NV, Boyd DG, et al.: Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 1997, 29: 115-122.
26. Kinoshita S, Sidhu A, Felder RA: Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989, 84: 1849-1856.
27. Debska-Slizien A, Ho P, Drangova R, Baines AD: Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol 1994, 5: 1125-1132.
28. Hussain T, Lokhandwala MF: Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K+-ATPase in kidney of spontaneously hypertensive rats. Clin Exp Hypertens 1996, 18: 963-974.
29. Kunimi M, Seki G, Hara C, et al.: Dopamine inhibits renal Na+: HCO3-cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 2000, 57: 534-543.
30. Sanada H, Jose PA, Hazen-Martin D, et al.: Dopamine-1 receptor defect in renal proximal tubular cells in essential hypertension. Hypertension 1999, 33: 1036-1042.
31. Felder RA, Sanada H, Xu J, et al.: Activating mutations in human essential hypertension. Proc Natl Acad Sci U S A 2002, 99: 3872-3877.
32. Chatziantoniou C, Ruan X, Arendshorst WJ: Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci U S A 1995, 92: 2924-2928.
33. de Vries PA, Navis G, de Jong PE, et al.: Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol 1999, 34: 191-198.
34. Lucas-Teixeira VA, Vieira-Coelho MA, Serrao P, et al.: Salt intake and sensitivity of intestinal and renal Na+-K+ ATPase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin Exp Hypertens 2000, 22: 455-469.
35. Xu J, Li XX, Albrecht FE, et al.: D1 receptor, Gsa, and Na+/H+ exchanger interactions in the kidney in hypertension. Hypertension 2000, 36: 395-399.
36. Chen C, Beach RE, Lokhandwala MF: Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 1993, 21: 364-372.
37. Zhong H, Neubig RR: Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther 2001, 297: 837-845.
38. Ross EM, Wilkie TM: GTPase-activating proteins for heterotri-meric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Ann Rev Biochem 2000, 69: 795-827.
39. Zheng B, Ma YC, Ostrom RS, et al.: RGS-PX1, a GAP for GaS and sorting nexin in vesicular trafficking. Science 2001, 294: 1939-1942.
40. Patel TB, Du Z, Pierre S, et al.: Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 2001, 269: 13-25.
41. Siffert W, Rosskopf D, Siffert G, et al.: Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998, 18: 45-48.
42. Felder RA, Kinoshita S, Ohbu K, et al.: Organ specificity of the dopamine-1 receptor/adenylyl cyclase coupling defect in the spontaneously hypertensive rat. Am J Physiol 1993, 264: R726-R732.
43. Bek MJ, Zheng S, Xu J, et al.: Differential expression of adenylyl cyclase in the rat nephron. Kidney Int 2001, 60: 890-899.
44. Michel MC, Siepmann F, Büscher R, et al.: Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. I. Renal a1-a2-, and b-adrenergic receptors and their signaling. Hypertension 1993, 22: 169-177.
45. Hussain T, Lokhandwala MF: Renal dopamine DA1 receptor coupling with GS and Gq/11 proteins in spontaneously hypertensive rats. Am J Physiol 1997, 272: F339-F346.
46. Horiuchi A, Albrecht FE, Eisner GM, et al.: Renal dopamine receptors and pre- and post-cAMP mediated sodium transport defect in the spontaneously hypertensive rat. Am J Physiol 1992, 263: F1105-F1111.
47. Michel MC, Farke W, Erdbrugger W, et al.: Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats. Hypertension 1994, 23: 653-658.
48. Ladines CA, Zeng C, Asico LD, et al.: Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2001, 281: R1071-R1078.
49. Gurich RW, Beach RE, Caflisch CR: Cloning of the alpha-sub-unit of GS protein from spontaneously hypertensive rats. Hypertension 1994, 24: 595-999.
50. Ortiz PA, Garvin JL: Intrarenal transport and vasoactive substances in hypertension. Hypertension 2001, 38[part 2]: 621-624.
51. Li XX, Albrecht FE, Robillard JE, et al.: Gb Regulation of Na-H exchanger-3 activity in rat renal proximal tubules during development. Am J Physiol Regul Integr Comp Physiol 2000, 278: R931-R936.
52. Sela S, White BH, Uh M, et al.: Dysfunctional D1A receptor-G-protein coupling in proximal tubules of spontaneously hypertensive rats is not due to abnormal G-proteins. J Hypertens 1997, 15: 259-267.
53. Sanada H, Xu J, Watanabe H, et al.: Differential expression and regulation of dopamine-1 (D1) and dopamine-5 (D-5) receptor function in human kidney [abstract]. Am J Hypertens 2000, 13: 156A.
54. Ferguson SS: Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001, 53: 1-24.
55. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ: Regulation of receptor fate by ubiquitination of activated b2-adrenergic receptor and b-arrestin. Science 2001, 294: 1307-1313.
56. Tiberi M, Nash SR, Bertrand L, et al.: Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J Biol Chem 1996, 271: 3771-3778.
57. Vickery RG, von Zastrow M: Distinct dynamin-dependent and - independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J Cell Biol 1999, 144: 31-43.
58. Jiang D, Sibley DR: Regulation of D1 dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization. Mol Pharmacol 1999, 56: 675-683.
59. Gardner B, Liu ZF, Jiang D, Sibley DR: The role of phosphorylation/ dephosphorylation in agonist-induced desensitization of D1 dopamine receptor function: evidence for a novel pathway for receptor dephosphorylation. Mol Pharmacol 2001, 59: 310-321.
60. Yu P, Asico LD, Eisner GM, et al.: Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension 2000, 36: 1053-1058.
61. Pitcher JA, Payne ES, Csortos C, et al.: The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. Proc Natl Acad Sci U S A 1995, 92: 8343-8347.
62. Gros R, Chorazyczewski J, Meek MD, et al.: G-Protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 2000, 35: 38-42.
63. Ishizaka N, Alexander RW, Laursen JB, et al.: G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta. Regulation by angiotensin II and hypertension. J Biol Chem 1997, 272: 32482-32488.
64. Williams SM, Addy JA, Phillips JA III, et al.: Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000, 36: 2-6.
65. Casari G, Barlassina C, Cusi D, et al.: Association of the alpha-adducin locus with essential hypertension. Hypertension 1995, 25: 320-326.
66. Beaumont V, Hepworth MB, Luty JS, et al.: Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration. J Biol Chem 1998, 273: 33174-3383.
67. Gray JA, Sheffler DJ, Bhatnagar A, et al.: Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine2A receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Mol Pharmacol 2001, 60: 1020-1030.
68. George SR, Lee SP, Varghese G, et al.: A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem 1998, 273: 30244-30248.
69. Yu PY, Hopfer U, Felder RA, Jose PA: Increased serine-phosphorylation of the D1 receptor in renal proximal tubule cells in hypertension [abstract]. Am J Hypertens 2000, 13: 12A-13A.
70. Jung MY, Skryabin BV, Arai M, et al.: Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience 1999, 91: 911-924.
71. Nimchinsky EA, Hof PR, Janssen WG, et al.: Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem 1997, 272: 29229-29237.
72. Milligan G, White JH: Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol Sci 2001, 22: 513-518.
73. Levavi-Sivan B, Park BH, Fuchs S, Fishburn CS: Human D3 dopamine receptor in the medulloblastoma TE671 cell line: cross-talk between D1 and D3 receptors. FEBS Lett 1998, 439: 138-142.
74. Zeng C, Yu P, Zheng S, et al.: D3 dopamine receptors positively regulate D1 dopamine receptors and negatively regulate AT1 angiotensin receptors [abstract]. J Am Soc Nephrol 2001, 12: 2467A.
75. Li XX, Bek M, Asico LD, et al.: Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 2001, 38: 303-308.
76. Scarselli M, Novi F, Schallmach E, et al.: D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 2001, 276: 30308-30314.
77. Schwark JR, Jansen HW, Lang HJ, et al.: S3226, a novel inhibitor of Na+/H+ exchanger subtype 3 in various cell types. Pflugers Arch 1998, 436: 797-800.
78. Vuagnat A, Giacche M, Hopkins PN, et al.: Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med 2001, 79: 175-183.
79. Cvetkovic B, Sigmund CD: Understanding hypertension through genetic manipulation in mice. Kidney Int 2000, 57: 863-874.
80. Audoly LP, Le TH, Coffman TM: What can knockout mice contribute to an understanding of hypertension? Curr Hypertens Rep 2000, 2: 192-197.
81. Yamaguchi I, Yao L, Sanada H, et al.: Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension 1997, 29: 962-968.
82. Cheng H-F, Becker BN, Harris RC: Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 1996, 97: 2745-2752.
83. Chen C-J, Apparsundaram S, Lokhandwala MF: Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther 1991, 256: 486-491.
84. Villard E, Tiret L, Visvikis S, et al.: Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996, 58: 1268-1278.
85. Stoll M, Cowley AW Jr, Tonellato PJ, et al.: A genomic-systems biology map for cardiovascular function. Science 2001, 294: 1723-1726.
86. Haynes WG, Hand MF, Dockrell ME, et al.: Physiological role of nitric oxide regulation of renal function in humans. Am J Physiol 1997, 272: F364-F371.
87. Lonart G, Cassels KL, Johnson KM: Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices. J Neurosci Res 1993, 35: 192-198.
88. Venkatakrishnan U, Chen C, Lokhandwala MF: The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Clin Exp Hypertens 2000, 22: 309-324.
89. Sanada H, Junichi Y, Sanae M, et al.: In vivo inhibition of the renal D1 dopamine receptor kinase with antisense oligode-oxynucleotide normalizes blood pressure in spontaneously hypertensive rats [abstract]. J Am Soc Nephrol 2001, 12: 472A.
90. Zhuang X, Belluscio L, Hen R: Golf mediates dopamine D1 receptor signaling. J Neurosci 2000, 20: RC91: 1-5.
91. Herve D, Le Moine C, Corvol JC, et al.: Galpha olf levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 2001, 21: 4390-4399.
92. Uh M, White BH, Sidhu A: Alteration of association of agonist-activated renal D1A dopamine receptors with G proteins in proximal tubules of the spontaneously hypertensive rat. J Hypertens 1998, 16: 1307-1313.
93. Jin LQ, Wang HY, Friedman E: Stimulated D1 dopamine receptors couple to multiple Ga proteins in different brain regions. J Neurochem 2001, 78: 981-990.